UK markets closed
  • NIKKEI 225

    27,782.42
    +200.76 (+0.73%)
     
  • HANG SENG

    26,315.32
    +841.44 (+3.30%)
     
  • CRUDE OIL

    73.57
    +1.18 (+1.63%)
     
  • GOLD FUTURES

    1,834.90
    +30.30 (+1.68%)
     
  • DOW

    35,116.63
    +185.70 (+0.53%)
     
  • BTC-GBP

    28,300.02
    -897.60 (-3.07%)
     
  • CMC Crypto 200

    931.78
    +1.42 (+0.15%)
     
  • ^IXIC

    14,793.47
    +30.88 (+0.21%)
     
  • ^FTAS

    4,054.12
    +30.04 (+0.75%)
     

Here's Why Altimmune Stock Is Surging Today

·2-min read
Here's Why Altimmune Stock Is Surging Today

Shares of Altimmune (NASDAQ: ALT), a clinical-stage biopharmaceutical company, are on the move following a positive clinical readout. Investors excited about the company's potential new weight loss drug drove the stock 23% higher as of 12:34 p.m. on Wednesday. Altimmune's weight loss drug candidate, ALT-801, is a GLP-1 receptor agonist that also activates glucagon receptors.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting